Reducing liver function tests for statin monitoring: an observational comparison of two clinical commissioning groups

BACKGROUND: Current liver function testing for statin monitoring is largely unnecessary and costly. Statins do not cause liver disease. Both reduction in test frequency and use of a single alanine transaminase (ALT) rather than a full seven analyte liver function test (LFT) array would reduce cost a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Gen Pract
Main Authors: Homer, Kate, Robson, John, Solaiman, Susannah, Davis, Abigail, Khan, Saima Zubeda, McCoy, David, Mathur, Rohini, Hull, Sally, Boomla, Kambiz
Formato: Artigo
Idioma:Inglês
Publicado em: Royal College of General Practitioners 2017
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5325661/
https://ncbi.nlm.nih.gov/pubmed/28137784
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3399/bjgp17X689365
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados